SecBot SecBot
6-K ·Filed Jun 12, 2026

CXXIF

C21 Investments Inc.
MIXED
Impact 5/10
Horizonmonths Processed5mo ago SEC0001062993-26-003165
Notable filing: 6-K
Actionable Insight ◆ Mixed

Operational improvements are clear (revenue growth, margin stability, customer growth) but the massive uncertain tax position and ongoing net losses temper the positive read-through. Watch for updates on the IRS's position on Section 280E rescheduling and the June 29, 2026 DEA hearings on adult-use cannabis. Positive cash flow suggests no near-term liquidity crisis, but the tax overhang could constrain capital allocation.

DirectionMixed
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$0.2700
T+0 close · Jun 12, 2026 · via day close
Latest settled
−11.56%
T+20 · $0.2388
Vs SPY
−12.82%
α at T+20
Next horizon
T+60
due 2mo ago
  1. T+0 · Jun 12 $0.2700entry
  2. T+1 · 5mo ago −7.78%α −9.54% · $0.2490
  3. T+5 · 5mo ago −8.70%α −9.32% · $0.2465
  4. T+20 · 4mo ago −11.56%α −12.82% · $0.2388
  5. T+60 · due 2mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

C21 Investments reported FY2026 results with revenue of $32.6M (+8.3% YoY), operating income of $2.3M (+78% YoY), and Adjusted EBITDA of $5.5M (+13% YoY). The company generated positive operating cash flow of $1.36M and improved to a working capital surplus of $1.9M from a $0.5M deficit last year. However, a $4.6M income tax expense (driven by the company's position that IRC Section 280E does not apply) kept net loss at $3.2M, and the uncertain tax liability grew to $13.4M. The filing also notes the recent rescheduling of medical marijuana to Schedule III, which could reduce tax burden over time.

Key Facts

  • Revenue increased 8.3% to $32.6M (FY2026 vs FY2025: $30.1M)
  • Gross margin stable at 41.7%
  • Income from operations rose 78% to $2.3M
  • Net loss narrowed to $3.2M from $4.0M
  • Adjusted EBITDA grew 13% to $5.5M
  • Positive operating cash flow of $1.36M (flat YoY)
  • Working capital surplus of $1.9M vs deficiency of $0.5M last year
  • Record 725,000 customer transactions (up 16% YoY)
  • Uncertain tax position ballooned to $13.4M due to Section 280E challenge
  • Convertible debentures reduced to $732,638 (all current) from $1.69M last year
  • DEA rescheduled medical marijuana to Schedule III on April 28, 2026
  • Litigation settlement (EFF) resulted in $443K loss; $1.1M paid during the year

Financial Impact

Revenue up $2.5M, operating income up $1.0M, net loss reduced by $0.7M. Tax overhang of $13.4M remains unresolved.

revenueoperating incomenet incomeincome tax liabilityworking capitaldebt

Risk Factors

  • IRS challenge to the Section 280E tax position could require large cash outflows
  • Adult-use cannabis remains federally illegal; enforcement risk persists
  • Price compression in Nevada market and state sales down 10% YoY
  • High debt service on convertible debentures ($1.3M repaid in FY2026)
  • Accumulated deficit of $80M and negative shareholders' equity of $25.4M

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001062993-26-003165
Exhibit: exhibit99-2.htm0001062993-26-003165
Exhibit: exhibit99-5.htm0001062993-26-003165

Track record

4 reports on CXXIF

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Aug 21, 202612w ago 6-K Bearish 5/10 Entry $0.2590 No price data
  2. Jun 15, 202622w ago 6-K Bullish 7/10 Entry $0.2490 to $0.2390 ▼ −4.02% −3.88% vs SPY
  3. Jun 12, 202622w ago 20-F Mixed 5/10 Entry $0.2700 to $0.2388 ▼ −11.56% −12.82% vs SPY
  4. Jun 12, 202622w ago 6-K Mixed 5/10 Viewing Entry $0.2700 to $0.2388 ▼ −11.56% −12.82% vs SPY
Showing 4 of 4

US Market Status

Market Closed · Opens in 5h 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026